Achieve Life Sciences

ACHVNasdaq United States Health Care Biotechnology: In Vitro & In Vivo Diagnostic Substances

Market cap

$658.061 M

$6.40 -8.38%

Close of 6 Nov 2026

As of 6 Nov 2026, Achieve Life Sciences (ACHV) has a market capitalization of $658.1M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$54.6M

Loss-making

Shares outstanding

102,902,490

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: In Vitro & In Vivo Diagnostic Substances, ranked by market cap

All 19 →

#6Intellia TherapeuticsNTLA$1.56B
#7QuidelOrthoQDEL$886.3M
#8Achieve Life SciencesACHV$658.1M
#9Myriad GeneticsMYGN$597.3M
#10Anbio BiotechnologyNNNN$529.5M

What if Achieve Life Sciences were worth as much as…

Open the what-if tool →

Gold $28.2T

$274,404.18

Per share 42,909× higher

Bitcoin $1.53T

$14,847.53

Per share 2,322× higher

Apple $5.02T

$48,743.06

Per share 7,622× higher

Or at a round number

$1.00B $2.00B $5.00B $10.0B

Where these numbers come from

Share counts and financials for Achieve Life Sciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.